These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1645692)

  • 21. [Biweekly menopausal substitutive hormone therapy: effects on climacteric and prevention of osteoporosis].
    Zylberberg B; Dormont D
    Contracept Fertil Sex; 1996 Dec; 24(12):874-8. PubMed ID: 9026274
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gyneco-urologic problems in climacteric].
    Enzelsberger H
    Wien Med Wochenschr; 1992; 142(5-6):115-9. PubMed ID: 1615679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Equine estrogens vs. esterified estrogens in the climacteric and menopause. The controversy arrives in Mexico].
    Velasco-Murillo V
    Gac Med Mex; 2001; 137(3):237-42. PubMed ID: 11432092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mydocalm treatment of muscular and vascular complaints accompanying climacterics.
    Sásdi A
    Ther Hung; 1992; 40(2):83-5. PubMed ID: 1462282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefits of post-menopausal hormone therapy.
    van der Schouw YT; Grobbee DE
    Eur Heart J; 2005 Jul; 26(14):1358-61. PubMed ID: 15860515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential use of conjugated estrogens and medroxyprogesterone in the climacteric syndrome: clinical and histological findings.
    Figueroa-Casas PR; Schlaen I
    Maturitas; 1988 Mar; 9(4):309-13. PubMed ID: 2837619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Requiem for hormone replacement therapy? This does not apply to modern preparations!].
    Lippert TH; Mueck AO
    MMW Fortschr Med; 2003 Sep; 145(37):13; author reply 13-4. PubMed ID: 14584434
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of a continuous estrogen-progestin regimen in the menopausal patient.
    Weinstein L
    Obstet Gynecol; 1987 Jun; 69(6):929-32. PubMed ID: 3574823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical effectiveness of a new matrix plaster: an overview].
    Schindler AE; Schindler EM
    Zentralbl Gynakol; 1995; 117(10):508-9. PubMed ID: 7491832
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of the effect of fluoxetine combined with hormone replacement therapy (HRT) and single HRT in treating menopausal depression].
    Yu Q; Yin CX; Hui Y; Yu J; He FF; Wei J; Wu YY
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):461-4. PubMed ID: 15347469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
    Hargrove JT; Maxson WS; Wentz AC; Burnett LS
    Obstet Gynecol; 1989 Apr; 73(4):606-12. PubMed ID: 2538787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?
    Haskell SG; Bean-Mayberry B; Gordon K
    Menopause; 2009; 16(3):494-9. PubMed ID: 19182695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen replacement therapy.
    Alcoff JM
    Am Fam Physician; 1982 Jun; 25(6):183-6. PubMed ID: 6282102
    [No Abstract]   [Full Text] [Related]  

  • 37. [Estrogens in menopause--therapy and prevention. I. Hormone substitution in climacteric and postmenopause].
    Wuttke W
    Internist (Berl); 1996 Apr; 37(4):402-5. PubMed ID: 8655280
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hormone substitution therapy. Side-effects and compliance of various therapeutic regimens].
    Perrone G; Barillaro F; Bazzoffi R; Capri O; Critelli C; Galoppi P; Grande S; Santoro G
    Minerva Ginecol; 1999 Mar; 51(3):53-8. PubMed ID: 10352534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
    Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life in climacteric Chilean women treated with low-dose estrogen.
    Aedo S; Schiattino I; Cavada G; Porcile A
    Maturitas; 2008 Nov; 61(3):248-51. PubMed ID: 18818032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.